Fauna Bio Announces Strategic Collaboration with Lilly to Discover Novel Obesity Targets Using Convergence™ AI Platform

EMERYVILLE, Calif., Dec. 21, 2023 /PRNewswire/ — Fauna Bio, a biotechnology company improving human health by leveraging animal genomics, today announced a multi-year agreement with Eli Lilly and Company to apply Fauna’s Convergence™ artificial intelligence (AI) platform to support…

Click here to view original post

Advertisement — Advertise with Biotech Networks